Home Health International, Inc. (HHII) Accepts Contract Terms to Provide Patients With Dietary Supplements

  Home Health International Inc. (PINKSHEETS: HHII), a Medicare-certified home health agency and durable medical equipment (DME) supplier, announced today that it has accepted initial contract terms for an FDA approved supplement company to supply its patients with needed treatments and vitamins at considerable discounts.

The focus of the supplements will be on baby boomers and seniors and will include the creation of an exclusive product line for a large segment of the home health population. The products include Krill Oil, Glucosamine, Vitamins A & D, and Calcium & Vitamin D in addition to a blood pressure supplement currently in production. This product distribution represents a new revenue stream for Home Health International and the Company is eager to move forward on the final contract.

For more information about Home Health International Inc., visit the corporate website at www.homehealthintl.com.

About Home Health International Inc. Home Health International Inc. was incorporated in the State of Nevada on September 13, 2006. The Company was formerly known as Micro Mammoth Solutions, Inc. and operated as such until January 25, 2010. On January 26, 2010, the Board of Directors of the Company approved a Stock Purchase Agreement between the Company and all of the shareholders of Atlas Capital Partners, LLC. Following the acquisition of Atlas Capital Partners the shareholders approved an amendment to the Company's Articles of Incorporation changing the Company's name from Micro Mammoth Solutions, Inc. to Atlas Capital Holdings, Inc. The Company received shareholder and board approval to amend its Articles of Incorporation to change its name to Home Health International Inc. This change was approved by FINRA and became effective on March 26, 2012.

Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Home Health International Inc. undertakes no obligation to update such statements.

CONTACT: Home Health International Inc. [e-mail]